posed of multiple cysts (>6) of varying sizes, from a few millimeters up to two centimeters. External lobulations and a stellate pattern are commonly present. Fibrous central scars with or without a characteristic stellate pattern of calcification are seen in 30% of cases and are highly specific to serous A 69-year-old asymptomatic woman with a pancreatic cystic mass incidentally detected on a sonographic examination. The contrast-enhanced axial CT image (a) shows a 2.8 x 3.0 cm heterogeneous mass (arrowheads) with multiple coarse calcifications at the junction of the body and neck of the pancreas. It is difficult to predict whether the mass is solid or cystic. An axial, heavily T2-weighted MR image (b) clearly shows that the mass consists of multiple, small, hyperintense cysts (arrowheads). Note the enhancement of the fibrous septations on an axial, fat-suppressed, gradient-echo T1-weighted image (c) that was obtained following IV gadolinium administration, which is typical for a serous cystadenoma. b a Figure 3 . A 62-year-old woman who presented with a palpable epigastric mass. A contrast-enhanced axial CT image shows a large cystic pancreatic mass (arrowheads) composed of multiple cysts of varying sizes. A thin cyst wall and central calcifications (arrow) are highly characteristic of a serous cystadenoma. c cystadenomas (3) (Fig. 3) . The fibrous portion of the tumor shows enhancement with an IV contrast medium on CT or magnetic resonance imaging (MRI) evaluations. This enhancement pattern is an important distinguishing feature that differentiates this type of tumor from other cystic pancreatic neoplasms. On CT examination, a tumor that is composed of primarily microscopic cysts can have a solid appearance. In these cases, MRI can help to demonstrate microcysts as multiple, small, discrete, T2-bright-signal-intensity structures (Fig. 4) . The fibrous components are typically hypointense on T2-weighted MR images. Occasionally, serous cystadenomas may be seen as macrocystic or oligocystic variants and may be difficult to differentiate from MCT.
Mucinous cystic tumor (MCT, mucinous cystadenoma/cystadenocarcinoma)
Mucinous cystadenoma is characterized by a mucin-producing epithelium that lines a cystic cavity. It is a benign tumor with malignant potential and occurs more frequently in women who are in their fourth through sixth decades. The term "mother" lesion has been used due to the age and gender tendencies of this tumor (4) . MCTs are usually located in the body and tail of the pancreas and are commonly detected only after growing to large sizes (Fig. 5 ). They are typically unilocular but can also be multiloculated, containing six or fewer cysts measuring greater than 2 cm in diameter. Mucinous cystic tumors present as well-encapsulated masses with various intracystic appearances depending on their contents. Internal septations may or may not be visualized. Enhancement of the cyst wall or septations may be b a c seen following contrast administration. Peripheral curvilinear calcification of the cyst wall has been reported in 10-25% of these tumors (2, 6, 7) .
The most important differential diagnosis of MCT is a pseudocyst. Although a history of pancreatitis, alcoholism, or pericystic/peripancreatic inflammatory changes favor pseudocysts, some cystic lesions may be radiologically indistinguishable. Needle aspiration of cystic fluid may be helpful in these cases; while levels of amylase increase in the cystic fluid of pseudocysts, CEA levels are elevated in many MCT cases. Because MCT is considered to be a low-grade malignant neoplasm, surgical excision is the treatment of choice. Mucinous cystadenocarcinoma may be very locally aggressive, with extensive invasion of adjacent tissues. The presence of a solid component, thick wall/septa and septal calcification may be suggestive of malignancy (8) . 
Intraductal papillary mucinous neoplasm (IPMN)
IPMN is a mucin-secreting, papillary proliferation of the epithelial lining of the pancreatic duct that leads to obstructive dilation of the main or side branch pancreatic ducts. It presents with a wide spectrum of characteristics, varying from hyperplasia and borderline lesions to adenocarcinoma (9) . In contrast to other common cystic pancreatic neoplasms, IPMN has increased prevalence in men older than 60 years. IPMNs are classified as main-duct, side-branch or combined types. The main-duct type of IMPN is characterized by segmental or diffuse dilatation of the main pancreatic duct, which may resemble chronic pancreatitis. The duct may be so much dilated as to resemble cysts. A dilated main pancreatic duct can be demonstrated with MRI, particularly using heavily T2-weighted or MR cholangiopancreaticography (MRCP) images (Fig. 6 ).
Side-branch type IPMN is more common in the uncinate process but may also involve the body or tail; it appears as a cluster of small cysts with lobulated margins and septations (2, 10, 11 ). An imaging diagnosis of sidebranch IPMN depends on identifying the communication of the cysts to the main pancreatic duct. This communication is generally best demonstrated by MRCP (Fig. 7) . Endoscopic retrograde cholangiopancreaticography (ERCP) may be helpful when MRCP fails to show any communication (Fig.  8) . The management of IPMN is determined by several factors, including the size and location of the tumor, the involvement of the main pancreatic duct, the associated soft tissue component, the patient's age and surgical risk factors. While surgery is typically considered the treatment of choice for larger cysts, cysts with an associated solid component and cysts in younger patients, imaging follow-up is recom- 
Solid pseudopapillary tumor (SPT)
SPT, also known as a solid and papillary epithelial neoplasm (SPEN), has low malignant potential and a favorable prognosis and is generally treated with surgical excision (12) . These tumors mainly occur in women in their second through fourth decades. Thus, the term "daughter" has been coined to describe this type of tumor (4) . Therefore, the cystic pancreatic tumor family consists of grandmother (serous cystadenoma), mother (mucinous cystadenoma) and daughter (solid and pseudopapillary) tumors. Although purely cystic or solid tumors are occasionally seen, the gross morphologic appearance of SPT is a large, encapsulated mass consisting of cystic and solid components. They typically have thick, well-defined capsules. CT, US and MR images may show internal heterogeneity due to hemorrhage and necrosis (Fig. 9) . Regions of hemorrhagic degeneration may appear as fluid-debris levels or high signal intensities on T1-weighted images (13) .
Uncommon cystic pancreatic tumors
Metastases, neuroendocrine tumors, teratomas, lymphangiomas, primary pancreatic adenocarcinomas and acinar cell carcinomas may occasionally be present as cystic masses. Pancreatic metastases may develop areas of central necrosis and resemble other cystic pancreatic neoplasms. Necrotic metastases occur most often in cases of aggressive metastatic tumors, such as sarcomas, melanomas and ovarian carcinomas (4) . Cystic degeneration or necrosis may also occur in pancreatic neuroendocrine tumors, adenocarcinomas and acinar cell carcinomas, usually when they grow to large sizes. Pancreatic neuroendocrine tumors, both functioning and nonfunctioning, may even appear completely cystic (14, 15 ). The extremely rare cystic pancreatic teratoma has a variable appearance on CT evaluation, including multilocular-cystic masses. Lymphangiomas are typically benign, predominantly multiloculated, cystic, well-circumscribed tumors. Although they may be found in any part of the pancreas, they most commonly arise in the body and tail (16) .
In conclusion, common pancreatic cystic tumors have characteristic imaging features, especially on MRI and MRCP examinations. Knowing these imaging features facilitates the accurate diagnosis and classification of these neoplasms and often prevents unnecessary radiological and surgical interventions. Radiologists should be aware of these imaging features and offer appropriate recommendations to accurately manage these tumors. 
